The central register of diabetes mellitus in the SSR keeps records of patients from birth to the age of 14 and 18 years resp. The health institution reports patients on special forms. At the end of the first half of 1988 574 patients from the entire SSR were on record. The incidence of diabetes mellitus in the last years is 6 per 100,000 children and has a slightly rising trend. The prevalence is (to the date of June 30, 1988) 34 in children under 14 years and by age groups it is 6 in children under 4 years, 29 in children under 9 years and 67 in children under 14 years per 100,000 children of the respective age group. This indicates increasing numbers of sick children with advancing age. The register records data from the family-history (incidence of diabetes, risk factors), from the patient's history at the time of the manifestation of the disease and during the period of data collection. The present state is evaluated on the basis of biochemical and clinical results. The state of compensation and quality of cooperation with the patient and parents are interlinked. In 284 families diabetes was present in another or several members (total 413) (genetic predisposition). Before the onset of diabetes mellitus 240 children an acute illness was recorded with a time interval of six weeks (infection and possible damage of islets). In addition to providing basic data for research of the disease, the register helps with dispensarization, statistical work, reports to doctors, inviting patients and planning the needs of sick children.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diabetes mellitus
16
children years
16
children
10
central register
8
register diabetes
8
incidence diabetes
8
years 100000
8
100000 children
8
years children
8
sick children
8

Similar Publications

Comprehensive review of animal models in diabetes research using chemical agents.

Lab Anim

January 2025

Kastamonu University, Faculty of Medicine, Department of Physiology, Kastamonu, Turkey.

Diabetes mellitus, characterized by insufficient insulin secretion and impaired insulin efficacy, disrupts carbohydrate, protein, and lipid metabolism. The global diabetic population is expected to double by 2025, from 380 million, posing a significant health challenge. Most diabetic individuals fall into the type 1 or type 2 categories, and diabetes adversely affects various organs, such as the kidneys, liver, nervous system, reproductive system, and eyes.

View Article and Find Full Text PDF

Sedentary lifestyles and prolonged physical inactivity are often linked to poor mental and physical health as well as an increased risk of a number of chronic illnesses, including cancer, obesity, type 2 diabetes, and cardiovascular problems. Metabolic Syndrome (MetS), as the new disease, has emerged as the world's leading cause of illness. Despite having its roots in the West, this issue has now completely globalized due to the development of the Western way of life throughout the world.

View Article and Find Full Text PDF

Background: Patients with end-stage kidney disease (ESKD) are at high risk for coronary artery disease. We investigate the trends and outcomes of percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in patients with ESKD.

Methods: We utilized the United States Renal Data System [2010-2018] to include adult patients with ESKD on dialysis for at least 3 months who underwent PCI for SIHD.

View Article and Find Full Text PDF

Enhancing metformin efficacy with cholecalciferol and taurine in diabetes therapy: Potential and limitations.

World J Diabetes

January 2025

Department of Anatomy, Division of Human Biology, School of Medicine, IMU University, Kuala Lumpur 57000, Malaysia.

Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), poses a significant global health challenge. Traditional management strategies primarily focus on glycemic control; however, there is a growing need for comprehensive approaches addressing the complex pathophysiology of diabetes complications. The recent study by Attia explores the potential of a novel therapy combining metformin with cholecalciferol (vitamin D3) and taurine to mitigate T2DM-related complications in a rat model.

View Article and Find Full Text PDF

Background: At present, the existing internal medicine drug treatment can alleviate the high glucose toxicity of patients to a certain extent, to explore the efficacy of laparoscopic jejunoileal side to side anastomosis in the treatment of type 2 diabetes, the report is as follows.

Aim: To investigate the effect of jejunoileal side-to-side anastomosis on metabolic parameters in patients with type 2 diabetes mellitus (T2DM).

Methods: We retrospectively analyzed the clinical data of 78 patients with T2DM who were treated jejunoileal lateral anastomosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!